ArticleAntimicrobial agents and chemotherapy2013

Phase I, open-label, single-dose study to evaluate the pharmacokinetics and safety of telbivudine in children and adolescents with chronic hepatitis B.

Daniel S Stein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.